Skip to main content
Premium Trial:

Request an Annual Quote

Glaxo Names Duke Researcher to Head Genetics Effort

Premium

RESEARCH TRIANGLE PARK, N.C.--Duke University researcher Allen Roses has been named director of Glaxo Wellcome's $48 million international genetics program. He will be based in the company's U.S. headquarters here and continue working at Duke as an adjunct professor. Previously, Glaxo Wellcome had funded Roses's Alzheimers research.

The Glaxo Wellcome genetics program employs 150 researchers in laboratories in the U.S., the U.K., and Switzerland. The company has said it expects the size of the department to double over the next 18 months.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.